Barclays PLC
14 March 2008
14 March 2008
Director/PDMR Shareholding: Disclosure and Transparency Rules 3.1.4R(1)(a)
1. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust (the 'ESAS Trust') notified Barclays PLC ('the Company') on 13 March
2008 that it had on 12 March 2008 exercised its discretion and released
shares following provisional allocations made by the trustee over the
Company's ordinary shares to participants in the Executive Share Award
Scheme ('ESAS'). Of these shares, the following were released to directors
and PDMRs of the Company:
+----------------+--------------+--------------+--------------+--------------+
|Directors/PDMRs |Shares |Shares sold |Price per |Shares |
| |released |on behalf of |share (pence) |retained by |
| |to Director/ |Director/PDMR | |Director/PDMR |
| |PDMR |to satisfy | | |
| | |withholding | | |
| | |liabilities | | |
| | | | | |
+----------------+--------------+--------------+--------------+--------------+
|Mr RE Diamond Jr| 1,197,379 | 506,600 | 460.50 | 690,779 |
+----------------+--------------+--------------+--------------+--------------+
|Mr GA Hoffman | 24,291 | 9,960 | 460.50 | 14,331 |
+----------------+--------------+--------------+--------------+--------------+
|Mr JS Varley | 29,261 | 11,998 | 460.50 | 17,263 |
+----------------+--------------+--------------+--------------+--------------+
|Mr PT Idzik | 171,501 | 70,316 | 460.50 | 101,185 |
+----------------+--------------+--------------+--------------+--------------+
2. The independent trustee of the ESAS Trust notified the Company on 13 March
2008 that it had on 12 March 2008 granted rights in the form of nil cost
options to the directors and PDMRs of the Company listed below under the
ESAS, to acquire ordinary shares in the Company. The ESAS options are
exercisable from grant until 7 March 2010 and are granted over a proportion
of the shares which were provisionally allocated by the trustee under ESAS
on 7 March 2005 to the directors and PDMRs listed below.
The number of shares under option includes an additional number of shares
which have been accrued in respect of dividends received by the trustee
since March 2005. The total exercise price payable on any exercise of an
ESAS option is £1.
Director Number of shares granted under option
to Directors/PDMRs
Mr GA Hoffman 64,896
Mr JS Varley 103,243
3. Appleby Nominees (Jersey) Limited notified the Company on 14 March 2008
that it had on 10 March 2008 exercised its discretion and allocated
reinvested dividend shares in Barclays PLC for the following directors/
PDMRs at a price of 456.06p per share:
Director Shares allocated to Director/PDMR
Mr RE Diamond Jr 56,261
Mr PT Idzik 11,197
The revised total shareholding for each director following these transactions is
as follows:
Director Beneficial Holding
Mr RE Diamond Jr 4,787,495
Mr GA Hoffman 446,092
Mr JS Varley 487,913
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.